Javascript must be enabled to continue!
Abstract 386: Dietary Oxidized Linoleic Acid Modulates PCSK9 and Associated Genes
View through CrossRef
Introduction:
We have previously shown that oxidized linoleic acid (OxLA) modulate plasma lipids. In this study we investigated the role of dietary OxLA on PCSK-9 and its associated genes.
Method:
Liver tissue from four groups of normal C57BL6 mice were feed; plain chow, chow supplemented with linoleic acid (9mg), chow supplemented with a low concentration of OxLA (9mg) and chow supplemented with a high concentration of OxLA (18mg) were analyzed for PCSK-9 and related genes. RNA from these livers samples was extracted with Trizol, assessed for purity by agarose gel electrophoresis and quantified using fluorometry. cDNA was synthesized from total extracted RNA and subsequently used for qRT-PCR analysis. Gene expressions of
PCSK-9, SREBP-1, HNF-1α
and
PPARα
were measured and normalized to
GAPDH
.
Total, free
and
cholesterol ester
levels in the liver were analyzed spectrophotometrically. Experiments were performed in triplicates and the difference between means was determined using a student’s T-test with a p value of <0.05 accepted as statistically significant.
Results:
PCSK-9 gene expression was markedly elevated in the mice fed high concentration OxLA, SREBP-1 gene levels in these of mice was also significantly elevated in comparison to the other 3 groups which had relatively the same levels of SREBP-1 gene expression. Conversely HNF-1α gene expression levels were elevated in all groups except the mice on low concentration OxLA. PPARα gene levels were significantly down regulated in the mouse on high concentration OxLA. Plasma total cholesterol levels were significantly elevated in both groups on OxLA.
Conclusion:
Elevated cholesterol levels in the livers of mice fed high concentration OxLA was accompanied with increased PCSK-9 expression. These results show that OxLA modulate PCSK-9 and its associated genes expression and promote accumulation of liver cholesterol.
Ovid Technologies (Wolters Kluwer Health)
Title: Abstract 386: Dietary Oxidized Linoleic Acid Modulates PCSK9 and Associated Genes
Description:
Introduction:
We have previously shown that oxidized linoleic acid (OxLA) modulate plasma lipids.
In this study we investigated the role of dietary OxLA on PCSK-9 and its associated genes.
Method:
Liver tissue from four groups of normal C57BL6 mice were feed; plain chow, chow supplemented with linoleic acid (9mg), chow supplemented with a low concentration of OxLA (9mg) and chow supplemented with a high concentration of OxLA (18mg) were analyzed for PCSK-9 and related genes.
RNA from these livers samples was extracted with Trizol, assessed for purity by agarose gel electrophoresis and quantified using fluorometry.
cDNA was synthesized from total extracted RNA and subsequently used for qRT-PCR analysis.
Gene expressions of
PCSK-9, SREBP-1, HNF-1α
and
PPARα
were measured and normalized to
GAPDH
.
Total, free
and
cholesterol ester
levels in the liver were analyzed spectrophotometrically.
Experiments were performed in triplicates and the difference between means was determined using a student’s T-test with a p value of <0.
05 accepted as statistically significant.
Results:
PCSK-9 gene expression was markedly elevated in the mice fed high concentration OxLA, SREBP-1 gene levels in these of mice was also significantly elevated in comparison to the other 3 groups which had relatively the same levels of SREBP-1 gene expression.
Conversely HNF-1α gene expression levels were elevated in all groups except the mice on low concentration OxLA.
PPARα gene levels were significantly down regulated in the mouse on high concentration OxLA.
Plasma total cholesterol levels were significantly elevated in both groups on OxLA.
Conclusion:
Elevated cholesterol levels in the livers of mice fed high concentration OxLA was accompanied with increased PCSK-9 expression.
These results show that OxLA modulate PCSK-9 and its associated genes expression and promote accumulation of liver cholesterol.
Related Results
Study of PCSK9 convertase in liver sinusoidal endothelial cells during colorectal carcinoma liver metastasis
Study of PCSK9 convertase in liver sinusoidal endothelial cells during colorectal carcinoma liver metastasis
Étude de la convertase PCSK9 dans les cellules endothéliales sinusoidales du foie au cours des métastases hépatiques du carcinome colorectal
Le cancer colorectal (C...
Le rôle du récepteur aux LDL et de PCSK9 dans le diabète de type 2
Le rôle du récepteur aux LDL et de PCSK9 dans le diabète de type 2
Les statines sont des médicaments hypolipémiants largement prescrits dans le cadre des maladies cardiovasculaires. Elles inhibent la synthèse endogène de cholestérol et induisent l...
Proprotein convertase subtilisin kexin 9 is associated with disease activity and is implicated in immune activation in systemic lupus erythematosus
Proprotein convertase subtilisin kexin 9 is associated with disease activity and is implicated in immune activation in systemic lupus erythematosus
Background Low-density lipoprotein (LDL) levels are increased by proprotein convertase subtilisin kexin 9 (PCSK9) which targets the LDL receptor. We recently reported that PCSK9 am...
Platelet-Derived PCSK9 Is Associated with LDL Metabolism and Modulates Atherothrombotic Mechanisms in Coronary Artery Disease
Platelet-Derived PCSK9 Is Associated with LDL Metabolism and Modulates Atherothrombotic Mechanisms in Coronary Artery Disease
Platelets play a significant role in atherothrombosis. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is critically involved in the regulation of LDL metabolism and interact...
PCSK9 ˸ études physiopathologiques et moléculaires
PCSK9 ˸ études physiopathologiques et moléculaires
Les maladies cardiovasculaires (MCV) dont fait partie l'athérosclérose, sont la principale cause de décès dans le monde et sont responsables de 17,9 millions de victimes chaque ann...
Proprotein Convertase Subtilisin/Kexin Type 9 Promotes Gastric Cancer Metastasis and Suppresses Apoptosis by Facilitating MAPK Signaling Pathway Through HSP70 Up-Regulation
Proprotein Convertase Subtilisin/Kexin Type 9 Promotes Gastric Cancer Metastasis and Suppresses Apoptosis by Facilitating MAPK Signaling Pathway Through HSP70 Up-Regulation
ObjectiveTo examine the effect of proprotein convertase subtilisin/kexin type 9 (PCSK9) on gastric cancer (GC) progression and prognosis, and to explore the underlying mechanism.Me...
PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Triggers Vascular Smooth Muscle Cell Senescence and Apoptosis: Implication of Its Direct Role in Degenerative Vascular Disease
PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Triggers Vascular Smooth Muscle Cell Senescence and Apoptosis: Implication of Its Direct Role in Degenerative Vascular Disease
Objective:
PCSK9 (proprotein convertase subtilisin/kexin type 9) plays a critical role in cholesterol metabolism via the PCSK9–LDLR (low-density lipoprotein receptor) a...
Abstract 318: Hepatic Site-1 Protease Knockdown in Mice Decreases Proprotein Convertase Subtilisin/kexin Type 9 Expression
Abstract 318: Hepatic Site-1 Protease Knockdown in Mice Decreases Proprotein Convertase Subtilisin/kexin Type 9 Expression
Introduction—
Site-1 protease (S1P) is a proprotein convertase involved in activation of transcription factors from their membrane-bound precursors in a process known a...

